Allowed
Macleods Pharmaceuticals Limited v. M/s.Apex Laboratories Pvt. Ltd.
Madras HCA/5938/2023
Case brief
from the order text
What is this about?
of 2023 A . No.5938 of 2023 in C.S. No.232…
What the court decided
AI extract
This page shows the compact analysis of this judgement. The full analysis — procedural history, issue-by-issue holdings with ratio and obiter, advocates, and paragraph-level evidence for every claim — is being added to the record in batches and will appear here when this judgement has been through it.
A. No.5938 of 2023 in C.S. No.232 of 2020
A. No.5938 of 2023
ABDUL QUDDHOSE, J.
Macleods Pharmaceuticals Limited ... Applicant vs.
The learned counsel for the respondent / plaintiff has stated no objection
for allowing this application, which has been filed to condone the delay of 369 days in representing the case papers in Appln. SR No.17511 of 2022 in C.S. No.232 of 2020.
2. This Court is satisfied with the reasons contained in the affidavit filed in support of this application as sufficient cause has been shown to condone the delay. Accordingly, this application is allowed as prayed for.
10.11.2023
vsi2
A. No.5938 of 2023
ABDUL QUDDHOSE, J.
vsi2
A. No.5938 of 2023 in C.S. No.232 of 2020
10.11.2023
1 provisions across 1 enactments
Macleods Pharmaceuticals Limited
The learned counsel for the respondent / plaintiff
ABDUL QUDDHOSE
As recorded by the court registry
Judgements on the same questions, provisions and authorities, from every court